CV Sciences Inc (CVSI): Conclusion: The systematic review conclu...

Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	3186
Boards Moderated	0
Alias Born	08/23/2022

Thomas@yahoo

Re: Wolf-man jack post# 84060

Friday, 07/04/2025 8:37:09 AM

Friday, July 04, 2025 8:37:09 AM

Conclusion: The systematic review concludes that CB2R agonists can effectively inhibit tumor growth while inducing apoptosis in various cancers.
https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-025-00289-5

The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD NOVEL FOODS approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel. ( GREAT NEWS FOR CV Sciences/ Cultured Foods.)
https://cannabishealthnews.co.uk/2025/07/02/fsa-publishes-new-guidance-thc-limits-daily-intake-cbd/

Bullish

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CVSI News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent CVSI News

More CVSI News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CVSI News

Go Ad-Free